Previous Page  5 / 20 Next Page
Information
Show Menu
Previous Page 5 / 20 Next Page
Page Background

• Wider therapeutic range

(mABs)

• Getting out from hospitals

(Insulins)

• Non-recombinant biosimilars

(LMWH)

why we care about biosimilars now

?